Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater
- PMID: 14654474
- DOI: 10.1245/aso.2003.07.512
Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater
Abstract
Background: Curative resection does not always equate with long-term survival. The aim was to identify patterns and predictors of failure and independent factors of prognosis after curative resection.
Methods: Sixty-six patients with ampullary carcinoma who underwent surgical intervention were reviewed. Fifty-nine patients underwent pancreaticoduodenectomy. Cox regression analysis, log-rank test, Fisher exact test, or chi(2) test was used.
Results: No patient died as a result of surgery; major complications occurred in three, and the 5-year survival rate after curative resection (n = 55) was 52.6%. Significant survival predictors were preoperative serum carcinoembryonic antigen level; gross tumor appearance; tumor, node, and tumor node metastasis stage; and microscopic lymphatic vessel and venous invasion in the primary tumor. Multivariate analysis demonstrated that lymphatic vessel invasion, tumor, and tumor node metastasis stage were significant independent prognostic factors. No patient experienced locoregional failure alone; all 24 relapsed patients had distant failure, and six of them had both. The liver was the most frequent metastatic organ, followed by nodes, peritoneum, lung, and bone. The carcinoembryonic antigen and carbohydrate antigen levels and lymphatic vessel and venous invasion were significant predictors of distant failure, and the mean time to relapse was 13 (range, 0.7-33) months.
Conclusions: Curative resection is associated with significant survival; however, effective systemic adjuvant therapy is needed to prevent distant failure for patients with elevated carcinoembryonic antigen and carbohydrate antigen levels or positive lymphatic vessel or venous invasion. A 3-year follow-up period would be necessary to document relapses.
Comment in
-
Carcinoma of the ampulla of vater: a distinct disease entity?Ann Surg Oncol. 2003 Dec;10(10):1136-7. doi: 10.1245/aso.2003.10.904. Ann Surg Oncol. 2003. PMID: 14654467 No abstract available.
Similar articles
-
Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.J Surg Oncol. 2007 Mar 15;95(4):286-90. doi: 10.1002/jso.20665. J Surg Oncol. 2007. PMID: 17326125
-
Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.Ann Surg Oncol. 2008 Nov;15(11):3178-86. doi: 10.1245/s10434-008-0099-4. Epub 2008 Aug 20. Ann Surg Oncol. 2008. PMID: 18712568 Clinical Trial.
-
Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.J Surg Oncol. 2012 Mar;105(3):266-72. doi: 10.1002/jso.22090. Epub 2011 Aug 31. J Surg Oncol. 2012. PMID: 21882202
-
Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.Ann Surg. 1989 Oct;210(4):544-54; discussion 554-6. doi: 10.1097/00000658-198910000-00015. Ann Surg. 1989. PMID: 2679459 Free PMC article. Review.
-
Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival.Surgery. 1995 Mar;117(3):247-53. doi: 10.1016/s0039-6060(05)80197-7. Surgery. 1995. PMID: 7878528 Review.
Cited by
-
Survival in ampullary cancer: potential role of different KRAS mutations.Surgery. 2015 Feb;157(2):260-8. doi: 10.1016/j.surg.2014.08.092. Surgery. 2015. PMID: 25616942 Free PMC article.
-
Intraductal dissemination of ampullary carcinoma after pancreatoduodenectomy.Surg Case Rep. 2019 Nov 8;5(1):176. doi: 10.1186/s40792-019-0740-4. Surg Case Rep. 2019. PMID: 31705212 Free PMC article.
-
Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma.Dig Dis Sci. 2008 Aug;53(8):2281-6. doi: 10.1007/s10620-007-0117-6. Epub 2007 Dec 20. Dig Dis Sci. 2008. PMID: 18095164
-
Long-term complete response of multiple hepatic metastases from carcinoma of the papilla of Vater using intrahepatic infusion of 5-FU with low-dose cisplatin following pancreaticoduodenectomy.Int J Clin Oncol. 2008 Dec;13(6):567-70. doi: 10.1007/s10147-008-0792-0. Epub 2008 Dec 18. Int J Clin Oncol. 2008. PMID: 19093189
-
Poorly differentiated adenocarcinoma with signet-ring cells in duodenal papilla: a case report.Surg Case Rep. 2017 Dec;3(1):14. doi: 10.1186/s40792-017-0287-1. Epub 2017 Jan 17. Surg Case Rep. 2017. PMID: 28097624 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources